Ongoing clinical studies
The programme consists of 4 global clinical studies, some of which might be happening in your country.
You can find more information about the studies running in your country below:
A study in people living with type 2 diabetes and overweight and/or obesity who are treated with insulin to assess the additional benefits of adding a combination study medicine to their therapy.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.
HQ23DI00119
Novo Nordisk (Pty) Ltd. Reg. No.: 1959/000833/07. 150 Rivonia Road,
10 Marion Street Office Park, Building C1, Sandton, Johannesburg,
2196.
Tel: (011) 202 0500 Fax: (011) 807 7989.
www.novonordisk.com. COMPONENT-046457 March 2024